City
Epaper

Russia rejects claims it stole AstraZeneca Covid jab formula from UK

By IANS | Updated: October 14, 2021 13:05 IST

New York, Oct 14 Russia has rebuffed accusations that its spies stole the "blueprint" for the Oxford-AstraZeneca vaccine ...

Open in App

New York, Oct 14 Russia has rebuffed accusations that its spies stole the "blueprint" for the Oxford-AstraZeneca vaccine and used it to create its own Sputnik V jab.

It's "scientific nonsense", the head of Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), was quoted as saying.

This week, British security services alleged that Russian spies stole and hacked UK's Covid vaccine data, according to a report in The Sun. Several other reports alleged that UK security services told British ministers they had solid proof against Russia.

However, RDIF called it "fake" and a "blatant lie", the report said.

"There is no merit [to these claims] and we're very clear about this," Kirill Dmitriev was quoted as saying to CNBC on Wednesday.

"This report is complete scientific nonsense, it has zero merit and frankly it's a lie," he added.

Russia's Sputnik jab uses similar technology to the AstraZeneca-Oxford designed vaccine.

The security teams are sure it was copied and it is understood the data was stolen by a foreign agent in person, the newspaper claimed.

Last year, spies blamed Russian president Vladimir Putin, saying they were "more than 95 per cent" sure that Russian state-sponsored hackers had targeted British, American and Canadian bodies developing a Covid vaccine, it added.

Dmitriev called the report "nonsense from anonymous sources" and said the accusations were part of a "smear campaign against Sputnik V because some politic don't like Russia and because some big pharma companies, who are afraid of the success of Sputnik V, continue to attack Sputnik V and Sputnik Light (its one-dose booster shot) from day one, so we're used to these attacks", he told CNBC's "Street Signs Europe."

He added that the country wants to partner other vaccine producers and is ready for a joint clinical trial taking place with AstraZeneca (to determine if mixed Covid vaccine doses work, the report said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Vladimir PutinCnbcKirill dmitrievRussian direct investment fundRdifConsumer industryCanadian company
Open in App

Related Stories

NationalVladimir Putin Accepts PM Modi’s Invitation To Visit India Preparations Underway, Says Russian FM Sergey Lavrov

InternationalDonald Trump, Russian President Vladimir Putin Speak Over Phone, Discuss Ending War in Ukraine: Report

OpinionsTrump’s victory puts Putin into spotlight!

NationalPM Narendra Modi to Visit Russia From October 22 to 23 to Attend BRICS Summit 2024

InternationalIndia Adopts Calculated and Strategic Stance Amid Russia-Ukraine Conflict

Health Realted Stories

HealthChemicals in food containers, medical equipment behind spike in heart disease deaths: Lancet

HealthWho’s Steering Indian Health Policy? COP11 Puts Foreign Interference in the Spotlight

HealthIsraeli researchers discovered stress in pregnancy affects baby's brain before birth

HealthJabalpur’s newborn gets life-saving heart treatment under Rashtriya Bal Swasthya Karyakram

HealthCovid-19 vaccines have no lasting impact on metabolic health: Study